Jemma Arakelyan, Medical Oncologist and CEO of Institute of Cancer and Crisis, shared a post on LinkedIn:
“Attending the Lindau Meeting was already a dream come true, but being selected to be on a panel with Nobel Laureate Professor Aaron Ciechanover, alongside Dr. Hagen Schroeter and Adam Smith, is surreal!
A huge thank you to Dr. Abigail Stevenson and Dr. Hagen Schroeter for believing in me and supporting my journey.
Grateful for this opportunity to represent the next generation of scientists!
Professor Aaron Ciechanover is an acclaimed Israeli biochemist best known for his pioneering research in the field of cellular regulation and protein degradation. He was awarded the Nobel Prize in Chemistry in 2004, along with Avram Hershko and Irwin Rose, for their discovery of the ubiquitin-proteasome pathway, a fundamental mechanism that regulates protein turnover in cells.”
More posts featuring Jemma Arakelyan on OncoDaily.